Analyst
Corporate Communications
Head of Investor Relations
Alnylam Pharmaceuticals, Inc. (ALNY)Equibles does not estimate personal net worth.
Christine Lindenboom is recorded as Analyst at Corporate Communications and Head of Investor Relations at Alnylam Pharmaceuticals, Inc. (ALNY). Christine Lindenboom has spoken on 18 earnings calls across 1 company, most recently for Alnylam Pharmaceuticals, Inc. on April 30, 2026. Alnylam Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alnylam Pharmaceuticals, Inc. includes Yvonne Greenstreet (CEO and COO), Yvonne L. Greenstreet (CEO, COO and Board Member), Amy W. Schulman (Chairman and Board Member) and 7 others.
“I'm Christina Kinch, Chief Corporate Communications Officer at El NILAM. With me today are Yvonne Greenstreet, Chief Executive Officer, Tolga Tangular, Chief Commercial Officer, Pushkol Guard, Chief Research and Development Officer, and Jeff Houlton, Chief Financial Officer.”
“With me today are Yvonne Greenstreet, Chief Executive Officer; Tolga Tanguler, Chief Commercial Officer; Pushkal Garg, Chief Medical Officer; and Jeff Poulton, Chief Financial Officer.”
“With me today are Yvonne Greenstreet, Chief Executive Officer; Tolga Tanguler, Chief Commercial Officer; Pushkal Garg, Chief Medical Officer; and Jeff Poulton, Chief Financial Officer.”
“With me today are Yvonne Greenstreet, Chief Executive Officer; Tolga Tanguler, Chief Commercial Officer; Pushkal Garg, Chief Medical Officer; and Jeff Poulton, Chief Financial Officer.”
“With me today are Yvonne Greenstreet, Chief Executive Officer; Tolga Tanguler, Chief Commercial Officer; Pushkal Garg, our Chief Medical Officer; and Jeff Poulton, Chief Financial Officer.”
Corporate Communications
Analyst
Source not stated
Biotechnology · Healthcare
Head of Investor Relations
